Details for Patent: 6,936,590
Summary for Patent: 6,936,590
| Title: | C-aryl glucoside SGLT2 inhibitors and method |
| Abstract: | A method is provided for treating diabetes and related diseases employing an SGLT2 inhibiting amount of a compound of the formula alone or in combination with one or more other antidiabetic agent(s) or other therapeutic agent(s). |
| Inventor(s): | William N. Washburn, Bruce Ellsworth, Wei Meng, Gang Wu, Philip M. Sher |
| Assignee: | AstraZeneca AB |
| Application Number: | US10/264,410 |
|
Patent Claim Types: see list of patent claims | Use; |
Drugs Protected by US Patent 6,936,590
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
